Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Advanz, Alzinova, Arcadia, Arcutis, Avobis, Cellectar, Cosmo, EG 427, Kashiv, Lexeo, Neurizon, Orca Bio, Precision Neuromed, Spruce.